Left ventricular hypertrophy (LVH) is a common finding in patients with hypertension. There is strong evidence that LVH plays an important role in the development of heart failure and is associated with a higher mortality rate in the hypertensive patients. 1 In addition, the parameters of elevated LV filling pressure (LVFP) are strongly related to LVH. 2 Many studies with echocardiography have shown that the ratio of early transmitral E wave velocity to early diastolic mitral annular E a wave velocity (E/E a ) correlates well with invasive measurement of LVFP 3 and correlates better with pulmonary capillary wedge pressure than brain natriuretic peptide in patients with cardiac disease. 4 In general, the measurement of an E/E a >15 is a reliable marker of increased LVFP. 5 The pulse wave velocity (PWV) reflects arterial stiffness, and it could be a marker of both the severity of vascular damage and the prognosis of cardiovascular diseases in patients with hypertension or abnormal glucose metabolism. 6, 7 Recently, brachial-ankle PWV (baPWV) measurement, which can be obtained simply by wrapping the four extremities with blood pressure (BP) cuffs, is now available as a means of measuring PWV. Now, baPWV has become a useful screening method for cardiovascular disease and as a test to assess the severity of atherosclerotic vascular damage in the general population. 8 However, it is not clear whether baPWV could be used to predict LVFP in the hypertensive patients with LVH.
Left ventricular hypertrophy (LVH) is a common finding in patients with hypertension. There is strong evidence that LVH plays an important role in the development of heart failure and is associated with a higher mortality rate in the hypertensive patients. 1 In addition, the parameters of elevated LV filling pressure (LVFP) are strongly related to LVH. 2 Many studies with echocardiography have shown that the ratio of early transmitral E wave velocity to early diastolic mitral annular E a wave velocity (E/E a ) correlates well with invasive measurement of LVFP 3 and correlates better with pulmonary capillary wedge pressure than brain natriuretic peptide in patients with cardiac disease. 4 In general, the measurement of an E/E a >15 is a reliable marker of increased LVFP. 5 The pulse wave velocity (PWV) reflects arterial stiffness, and it could be a marker of both the severity of vascular damage and the prognosis of cardiovascular diseases in patients with hypertension or abnormal glucose metabolism. 6, 7 Recently, brachial-ankle PWV (baPWV) measurement, which can be obtained simply by wrapping the four extremities with blood pressure (BP) cuffs, is now available as a means of measuring PWV. Now, baPWV has become a useful screening method for cardiovascular disease and as a test to assess the severity of atherosclerotic vascular damage in the general population. 8 However, it is not clear whether baPWV could be used to predict LVFP in the hypertensive patients with LVH.
We hypothesized that baPWV could be a noninvasive method for detecting increased LVFP in hypertensive LVH patients with preserved LV systolic function. We also evaluated for the relationship between Doppler echocardiographic parameters of LVFP and baPWV with B-type natriuretic peptide (BNP).
Methods
Study population. We enrolled 62 patients with LVH (31 patients with E/E a >15 and 31 patients with E/E a ≤15 satisfying
Background
The elevation of left ventricular filling pressure (LVFP) could be an important prognostic factor in patients with hypertension. We hypothesized that noninvasive brachial-ankle pulse wave velocity (baPWV) is associated with increased LVFP in hypertensive patients with LV hypertrophy (LVh).
Methods
We enrolled patients with well-controlled hypertension for more than 1 year with LV ejection fraction (LVEF) ≥55%, and LVh. The relationship between Doppler echocardiographic parameters of LVFP and baPWV with B-type natriuretic peptide (BNP) was also evaluated. results a total of 62 patients were enrolled (31 patients with E/E a >15 and 31 patients with E/E a ≤15) and the baPWV of the E/E a >15 group was significantly increased compared to the E/E a ≤15 group (1,664.3 ± 270.5 vs. 1,381.9 ± 159.1 cm/s, P < 0.01). The baPWV showed better correlation with E/E a (r = 0.69, P < 0.01) than the BNP (r = 0.47, P < 0.01). a multivariate linear regression model showed that only baPWV was significantly correlated with E/E a , and that the association was independent of other factors. The area under the receiveroperating characteristic (ROc) curve of baPWV for the detection of elevated LVFP (E/E a >15) was 0.79 (P < 0.01) and the optimal cutoff point of 1,440 cm/s produced 75% sensitivity and 62% specificity (the positive and negative predictive values were 68 and 71%, respectively).
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Brachial-Ankle Pulse Wave Velocity in Hypertension the following echocardiographic criteria), who visited the outpatient clinic of Hallym University Medical Center for the control of hypertension.
The inclusion criteria for the study are as follows: Patients were instructed to visit the hospital in a fasting state without smoking or ingesting caffeine or antihypertensive medications in the morning before the study. The institutional review board of Hallym Medical School approved this study and informed consent was obtained from all the study participants.
Echocardiographic assessment. One sonographer, blinded to the patient's information, performed echocardiography. The two-dimensional M-mode image was recorded using an echocardiography machine (Vivid 7; GE Medical Systems, Milwaukee, WI) according to the guidelines of the American Society of Echocardiology. 9 Measurements were made online and recorded digitally with participants' initials and study number as their only identification. Two cardiologists (M.K.K. and H.S.K.), blinded to the participants' clinical data, interpreted the echocardiogram in the off-line method.
For the estimation of LV diastolic function and LVFP, E/E a and deceleration time were assessed separately. LVM was quantified using the Devereux formula and the LVMI was defined by the patient's indexed body surface area. The LVH was defined as LVMI ≥115 g/m 2 for male and LVMI ≥95 g/m 2 for female. 10 The LVEF was quantified by Simpson's rule using the two-dimensional echocardiography images from the apical four-chamber view. 10 The intraobserver (k = 0.88) and interobserver (k = 0.90) reproducibility for E/E a were in the acceptable range.
Assessment of PWV. The baPWV was measured using a volume-plethysmographic apparatus (VP-2000; Colin, Komaki, Japan). The reliability of the equipment and the reproducibility of obtained measurements have been validated in previous clinical studies. 11, 12 Briefly, the patients were studied in a quiet, temperature-controlled room. Patients were instructed not to exercise, ingest caffeine, or smoke for at least 3 h before the study. Cuffs were connected to both plethysmographic and oscillometric sensors, with placement around both the arms and ankles while the subject remained in the supine position. The electrocardiogram electrodes were placed on both wrists, and a microphone for detecting heart sounds placed on the left edge of the sternum to detect the second heart sound. The time interval between the wave front of the brachial waveform and that of the ankle waveform was defined as the time interval between the brachium and ankle (DT ba ). The distance between sampling points of baPWV was calculated automatically according to the height of the patient. The path length from the suprasternal notch to the brachium (L b ) was obtained from superficial measurements and was expressed using the following equation: L b = (0.2195 × height of the subject (in cm) − 2.0734). The path length from the suprasternal notch to the ankle (L a ) was obtained from superficial measurements and was expressed using the following equation: L a = (0.8129 × height of the subject (in cm) + 12.328). Finally, the following equation was used to obtain baPWV: baPWV = ((L a − L b )/DT ba ). In this study, the left side baPWV was used for the analyses.
Statistical analysis. The continuous variables were summarized as mean ± s.d. Statistical differences between mean values were assessed using Student's unpaired t-test. Categorical variables are presented as numbers or percentages and were compared with χ 2 or Fisher's exact tests. Least squares linear regression was used to evaluate the association between E/E a and other clinical variables. Multivariable linear regression analysis was performed for studying the independent correlates of E/E a . Covariates, with P < 0.25, derived by univariate analysis were included in the multivariable model (expect potential intervening variables; E velocity, A velocity, and E a velocity). Potential collinearity was considered acceptable and the regression model stable at tolerance >0.60. To compare the utility of baPWV and BNP for the detection of elevated LVFP (E/E a >15), a receiver-operating characteristic (ROC) analysis was performed. Area under the ROC curve was measured as described by DeLong et al. 13 Data were analyzed using standard statistical software (SPSS, version 13.0; SPSS, Chicago, IL). P values <0.05 were considered statistically significant.
results
The 62 study participants (mean age 61 ± 7 years, 45% men) had a mean systolic BP of 124 ± 10 mm Hg, diastolic BP of 75 ± 7 mm Hg, mean arterial pressure of 92 ± 7 mm Hg, and heart rate of 64 ± 10 beats/min. The baseline clinical and laboratory findings of both groups are shown in Table 1 . There were no significant differences with regard to age, sex, body mass index, current smokers, and type 2 diabetes mellitus. The BP and heart rate were similar between the groups. The average class number of antihypertensive drug used was 1.65 ± 0.79. There were no differences in the type of antihypertensive drugs used between the groups. With regard to the baseline metabolic and risk profiles, there were no significant differences between both original contributions Brachial-Ankle Pulse Wave Velocity in Hypertension groups except for an elevated BNP level in the E/E a >15 group (27.7 ± 26.0 vs. 68.1 ± 57.7 pg/ml, P < 0.01). Table 2 shows the echocardiographic and PWV parameters of both groups. In the echocardiographic data, the LVMI, A velocity, deceleration time, E a , and E/E a values are significantly different between groups. The baPWV of E/E a >15 group was significantly increased compared to the E/E a ≤15 group (1,664.3 ± 270.5 vs. 1,381.9 ± 159.1 cm/s, P < 0.01). Univariate correlations of E/E a with a P value of <0.25 were age, BNP, LVMI, E velocity, A velocity, E a wave velocity, deceleration time, baPWV, and left ankle brachial index ( Table 3) . The baPWV showed better correlation with E/E a (r = 0.69, P < 0.01) than the BNP (r = 0.47, P < 0.01; Figure 1) . The significant effect of baPWV on E/E a in the multivariate model showed that the baPWV-E/E a association was independent of the other covariates including BNP ( Table 4) . The ROC curve analysis was performed to compare the utility of baPWV and BNP for the detection of elevated LVFP (E/E a >15). The overall performance of baPWV was equal to BNP (AUC: 0.79 vs. 0.79) and the optimal cutoff point of 1,440 cm/s produced 75% sensitivity and 62% specificity (the positive and negative predictive values were 68 and 71%, respectively; Figure 2 ).
discussion
The principal finding of this study was that, in the well-controlled hypertensive patients with LVH and preserved LV systolic function, baPWV was strongly correlated with the E/E a ratio, which is a marker of LVFP.
The PWV, which is well known to be an indicator of arterial stiffness and distensibility, 14 has been regarded as a marker of a vascular damage. The carotid-femoral PWV (cfPWV) obtained by noninvasive automatic devices is not only a marker of 
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Brachial-Ankle Pulse Wave Velocity in Hypertension atherosclerosis 15 but can also be an independent predictor for cardiovascular mortality in hypertensive patients. 6 In addition, cfPWV could be utilized for the detection of diastolic dysfunction in patients with early stages of essential hypertension. 16 The baPWV, with its technical simplicity and shorter sampling time compared to other noninvasive automatic devices, could serve as an indicator of either atherosclerotic cardiovascular risk or severity of vascular damage in general population. 8 Munakata et al. showed that baPWV had a good capability to predict the severity of organ damage in hypertensive patients. 11 In addition, Yu et al. recently reported that baPWV correlates batter than cfPWV with LV mass and diastolic dysfunction. 17 Because baPWV covers both central and peripheral arterial territories and cfPWV mainly reflects the stiffness of the central arteries, baPWV may be more representative than cfPWV as arterial load for LV. The possible mechanism of increased baPWV in increased LVFP is that stiff arteries can augment the aortic systolic pressure and decrease diastolic pressure. 18 The concentric remodeling and LVH could be promoted by the stiff arteries, which increase afterload during LV systole and relative reduction in coronary perfusion during LV diastole. 2, 19 This change can lead to diastolic dysfunction with increased LVFP and the progression of the subendocardial ischemia and interstitial fibrosis resulting in global systolic dysfunction. 20 Especially, in patients with suspected heart failure, who have preserved LVEF, the clinical question concerns the presence or absence of diastolic dysfunction. Tissue Doppler echocardiography is a novel technique, which directly measures regional myocardial tissue velocities and is used to quantitate the diastolic and systolic velocities of mitral annulus. Combining transmitral flow velocity with annular velocity (E/E a ) has been demonstrated to be a relatively load-independent measure of myocardial relaxation that correlates well with LVFP measured invasively in patients with cardiac disease. 3 Ommen et al. have shown that E/E a ratio has the highest predictive accuracy, and septal E/E a ratio has the best ROC curve for predicting mean LV diastolic pressure (mLVDP). It was previously noted that an E/E a >15 had 86% specificity (64% positive predictive value) for mean LV diastolic pressure >15 mm Hg. This was accurate when assessing patients with normal systolic function. 5 Using this sensitive echocardiographic technique, we can detect the early stages of LV diastolic dysfunction in hypertensive patients with normal LVEF without objective finding of heart failure.
The BNP is a cardiac neurohormone secreted from the ventricles and released in response to ventricular volume expansion and pressure overload. Elevations of the BNP have been reported to be a sensitive indicator of LV dysfunction among different etiologies including hypertension, myocardial infarction, systolic heart failure and also in patients with and BNP (white arrow) for the detection of E/E a >15. aUc, area under curve; baPWV, brachial-ankle pulse wave velocity; BNP, blood natriuretic peptide; cI, confidence interval; E/E a , the ratio of early diastolic mitral inflow velocity (E) and the early diastolic medial mitral annular velocity (E a ); NPV, negative predictive value; PPV, positive predictive value; ROc, receiver-operating characteristic. baPWV, brachial-ankle pulse wave velocity; BNP, blood natriuretic peptide; E/E a , the ratio of early diastolic mitral inflow velocity (E) and the early diastolic medial mitral annular velocity (E a ).
Brachial-Ankle Pulse Wave Velocity in Hypertension diastolic dysfunction with normal systolic function. 21 Although a low BNP level may preclude the need for echocardiography, Mottram et al. showed that the BNP level has limited diagnostic value in stable hypertensive patients with suspected diastolic dysfunction of LV. 22 In this study, baPWV showed better correlation over BNP with E/E a (r = 0.69 vs. r = 0.47). The ROC curves showed that the baPWV cutoff values of 1,440 cm/s to detect elevated LVFP (E/E a >15) had a high sensitivity and specificity. Based on our findings, hypertensive patients with wellcontrolled BP and normal LVEF who have elevated baPWV of >1,440 cm/s may have elevated LVFP with diastolic dysfunction irrespective of whether the patient has symptoms or not. Recently, Wang et al. reported that baPWV was significantly correlated with LV diastolic dysfunction detected by tissue Doppler image in hypertensive patients without cardiovascular events, indicating that baPWV may be an early indicator of LV dysfunction. 23 These findings may support our results.
As a general rule, the measurement of baPWV is more simple and inexpensive than Doppler echocardiography. This leaves baPWV as another noninvasive method for early detection of diastolic dysfunction in the well-controlled hypertensive patients with LVH.
limitations First, all of our patients were chronically treated with antihypertensive medications that may modify indices of baPWV and diastolic function and alter other physiological markers. 24 Although the antihypertensive medications of both groups were not different according to the χ 2 or Fisher's exact tests, we performed multivariable linear regression analysis, including the covariates in Table 3 , with forced inclusion of all the types of antihypertensive drugs. The independent association of baPWV with E/E a was consistent (data not shown). Nevertheless, the number of subjects in this study was relatively small, and the large number of covariates in the regression model may overload the model, leading to unpredictable errors. In addition, the number of subjects receiving some of the drug classes is quite low. Therefore, we could not completely exclude the interaction of antihypertensive drugs. Second, in cases when the baPWV values are high, confounding factors such as age, BP, blood flow, and sympathetic tone may increase the variability of baPWV. In this study the patient's age and BP levels were not significantly different between groups, negating their effects on baPWV measurements. The patients were also evaluated after resting in a quiet room with avoidance of caffeine and smoking as instructed. However, we cannot exclude all of these confounding factors and the effect they may have had on the baPWV values. Third, the major weakness of our study was that we did not have direct LVFP measurements of the study patients. Moreover, the noninvasive tests reported by others do not definitively validate the direct relationship between baPWV and LVFP. In addition, the study population was confined to well-controlled hypertensive patients. Therefore, our result may not be generalized into all patients.
In conclusion, we have demonstrated that elevated baPWV is associated with noninvasive markers of increased LVFP in hypertensive LVH patients with preserved LV systolic function. Further studies assessing the incremental value of baPWV as a screening tool for the development of diastolic dysfunction in hypertensive patients will be needed. baPWV, brachial-ankle pulse wave velocity; BNP, B-type natriuretic peptide; DT, deceleration time; E/E a , the ratio of early diastolic mitral inflow velocity (E) and the early diastolic medial mitral annular velocity (E a ); Lt. ABI, left ankle brachial index, LVMI, left ventricular mass index.
